PRO1107 in Patients With Advanced Solid Tumors
Genmab
Genmab
Accent Therapeutics
Pheon Therapeutics
Seagen Inc.
Fusion Pharmaceuticals Inc.
Blueprint Medicines Corporation
Alaunos Therapeutics
Artios Pharma Ltd
Tempus AI
Incyte Corporation
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Bio-Thera Solutions
Alaunos Therapeutics
Numab Therapeutics AG
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Pfizer
Pfizer
Seagen Inc.
Seagen Inc.
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Elucida Oncology
Haihe Biopharma Co., Ltd.
pharmaand GmbH
Fate Therapeutics
Xenetic Biosciences, Inc.
Zai Lab (Hong Kong), Ltd.
Novartis
PharmaMar
Incyte Corporation
Advenchen Laboratories, LLC
AbbVie
Ipsen
Pfizer
R-Pharm
Novartis
Otsuka Novel Products GmbH
CytoCore, Inc.
Cook Group Incorporated
Calando Pharmaceuticals